Lentivirus vector plasmid of Venus fluorescent protein driven by CMV promoter.
Catalog number | RDB05553 |
---|---|
Resource name | CSII-CMV-Venus |
Clone info. | Lentivirus vector plasmid of Venus fluorescent protein driven by CMV promoter. |
Comment | Commonly requested with pCMV-VSV-G-RSV-Rev (RDB04393) and pCAG-HIVgp (RDB04394). |
Vector backbone | CSII-CMV-MCS (Plasmid) |
Selectable markers | Ampicillin (E. coli). Please note that Zeo resistance marker is not included in the lentivirus produced from this vector. |
Gene/insert name | Aequorea victoria GFP cDNA |
Depositor|Developer | Miyoshi, Hiroyuki | |
Sequence (full) | RDB05553hts01.seq assembled from experimentally sequenced data |
---|---|
Remarks, protocol and/or map (pdf) | RDB05553.pdf |
Test sheet | RDB05553C0p1-1.pdf |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Ordering instruction.[link] |
---|---|
Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit academic purpose. The RECIPIENT agrees to expressly describe the late Dr. Hiroyuki Miyoshi as the Developer. |
Remarks | ((Remarks)) Remember that you will be working with samples containing infectious virus. Please contact us. We will provide you with appropriate documents. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 遺伝子組換え生物の受入れ確認書が必要です。当室にご請求ください。 手続きの概要は、「レンチウイルスベクターの提供申し込み」をご覧ください。 |
---|---|
MTAに書く使用条件 | 本件研究材料は、非営利機関の非営利学術研究に限って提供する。本件研究材料を利用した研究結果等を発表する際は、本件研究材料が故三好浩之博士により開発されたことを明示する。 |
備考 | 【使用上の注意】このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB05553 | CSII-CMV-Venus | DNA solution |
Materials & Methods section:
The CSII-CMV-Venus was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB05553). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
user_report | Lu, F., Down-regulated in renal cell carcinoma 1 (DRR1) regulates axon outgrowth during hippocampal neuron development. Biochem. Biophys. Res. Commun. 558: 36-43 (2021). PMID 33895549. [link to RRC of NBRP] |
---|---|
user_report | Mu, P., A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-κB degradation and cell growth suppression in neuroblastoma. Oncogene 36 (41): 5745-5756 (2017). PMID 28604741. [link to RRC of NBRP] |
user_report | Murakami-Tonami, Y., SGO1 is involved in the DNA damage response in MYCN-amplified neuroblastoma cells. Sci. Rep. 6: 31615 (2016). PMID 27539729. [link to RRC of NBRP] |
user_report | Nakaguro, M., Nucleolar protein PES1 is a marker of neuroblastoma outcome and is associated with neuroblastoma differentiation. Cancer Sci. 106 (3): 237-243 (2015). PMID 25557119. [link to RRC of NBRP] |
user_report | Murakami-Tonami, Y., Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells. Cell Cycle 13 (7): 1115-1131 (2014). PMID 24553121. [link to RRC of NBRP] |
user_report | Muraoka, N., MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. EMBO J., 33 (14): 1565-1581 (2014). PMID 24920580. [link to RRC of NBRP] |
user_report | Huang, P., The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma. Cancer Res., 71 (8), 2938-2948 (2011). PMID 21349947. [link to RRC of NBRP] |
Featured content